A non-randomized clinical trial to evaluate the effect of fingolimod on expanded disability status scale score and number of relapses in relapsing-remitting multiple sclerosis patients

BACKGROUND: Multiple sclerosis (MS) is a chronic disease characterized by demyelination, glial activation and axonal degeneration in the central nervous system. At the present, there is no certain remedy for this disease. However, available therapies often attenuate disease progress. METHODS: This s...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazdeh, Mehrdokht, Kargar Monhaser, Shahriar, Taheri, Mohammad, Ghafouri-Fard, Soudeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451934/
https://www.ncbi.nlm.nih.gov/pubmed/30957197
http://dx.doi.org/10.1186/s40169-019-0228-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451934/
https://www.ncbi.nlm.nih.gov/pubmed/30957197
http://dx.doi.org/10.1186/s40169-019-0228-7

Ejemplares similares